Cargando…

Immunization with Recombinant Accessory Protein-Deficient SARS-CoV-2 Protects against Lethal Challenge and Viral Transmission

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to a worldwide coronavirus disease 2019 (COVID-19) pandemic. Despite the high efficacy of the authorized vaccines, there may be uncertain and unknown side effects or disadvantages associated with current vaccination approaches. Liv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Chengjin, Park, Jun-Gyu, Chiem, Kevin, Dravid, Piyush, Allué-Guardia, Anna, Garcia-Vilanova, Andreu, Pino Tamayo, Paula, Shivanna, Vinay, Kapoor, Amit, Walter, Mark R., Kobie, James J., Plemper, Richard K., Torrelles, Jordi B., Martinez-Sobrido, Luis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269623/ https://www.ncbi.nlm.nih.gov/pubmed/37191507 http://dx.doi.org/10.1128/spectrum.00653-23

Ejemplares similares

Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice
por: Silvas, Jesus A., et al.
Publicado: (2021)

Monitoring SARS-CoV-2 Infection Using a Double Reporter-Expressing Virus
por: Chiem, Kevin, et al.
Publicado: (2022)

Analysis of SARS-CoV-2 infection dynamic in vivo using reporter-expressing viruses
por: Ye, Chengjin, et al.
Publicado: (2021)

A Bifluorescent-Based Assay for the Identification of Neutralizing Antibodies against SARS-CoV-2 Variants of Concern In Vitro and In Vivo
por: Chiem, Kevin, et al.
Publicado: (2021)

Generation and Characterization of Recombinant SARS-CoV-2 Expressing Reporter Genes
por: Chiem, Kevin, et al.
Publicado: (2021)

Selection, identification, and characterization of SARS-CoV-2 monoclonal antibody resistant mutants
por: Oladunni, Fatai S., et al.
Publicado: (2021)

Tuberculosis and COVID-19 in the elderly: factors driving a higher burden of disease
por: Allué-Guardia, Anna, et al.
Publicado: (2023)

Evolution of Drug-Resistant Mycobacterium tuberculosis Strains and Their Adaptation to the Human Lung Environment
por: Allué-Guardia, Anna, et al.
Publicado: (2021)

Rapid in vitro assays for screening neutralizing antibodies and antivirals against SARS-CoV-2
por: Park, Jun-Gyu, et al.
Publicado: (2021)

Mycobacteriophages as Potential Therapeutic Agents against Drug-Resistant Tuberculosis
por: Allué-Guardia, Anna, et al.
Publicado: (2021)

Host- and Age-Dependent Transcriptional Changes in Mycobacterium tuberculosis Cell Envelope Biosynthesis Genes after Exposure to Human Alveolar Lining Fluid
por: Allué-Guardia, Anna, et al.
Publicado: (2022)

Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice
por: Oladunni, Fatai S., et al.
Publicado: (2020)

Mitigation of SARS-CoV-2 by Using Transition Metal Nanozeolites and Quaternary Ammonium Compounds as Antiviral Agents in Suspensions and Soft Fabric Materials
por: Guerrero-Arguero, Israel, et al.
Publicado: (2023)

Modeling SARS-CoV-2 and Influenza Infections and Antiviral Treatments in Human Lung Epithelial Tissue Equivalents
por: Zarkoob, Hoda, et al.
Publicado: (2021)

New Developments and Insights in the Improvement of Mycobacterium tuberculosis Vaccines and Diagnostics Within the End TB Strategy
por: García, Juan Ignacio, et al.
Publicado: (2021)

SARS-CoV-2 B.1.1.7 and B.1.351 variants of concern induce lethal disease in K18-hACE2 transgenic mice despite convalescent plasma therapy
por: Horspool, Alexander M., et al.
Publicado: (2021)

Underestimated Manipulative Roles of Mycobacterium tuberculosis Cell Envelope Glycolipids During Infection
por: Garcia-Vilanova, Andreu, et al.
Publicado: (2019)

Antiviral activity of oleandrin and a defined extract of Nerium oleander against SARS-CoV-2
por: Plante, Kenneth S., et al.
Publicado: (2021)

Modeling SARS-CoV-2 and influenza infections and antiviral treatments in human lung epithelial tissue equivalents
por: Zarkoob, Hoda, et al.
Publicado: (2022)

Adenovirus-vectored T cell vaccine for hepacivirus shows reduced effectiveness against a CD8 T cell escape variant in rats
por: Hartlage, Alex S., et al.
Publicado: (2021)

Rapid Generation of Circulating and Mucosal Decoy Human ACE2 using mRNA Nanotherapeutics for the Potential Treatment of SARS‐CoV‐2
por: Kim, Jeonghwan, et al.
Publicado: (2022)

A Broad and Potent H1-Specific Human Monoclonal Antibody Produced in Plants Prevents Influenza Virus Infection and Transmission in Guinea Pigs
por: Park, Jun-Gyu, et al.
Publicado: (2020)

SARS-CoV-2 prefusion spike protein stabilized by six rather than two prolines is more potent for inducing antibodies that neutralize viral variants of concern
por: Lu, Mijia, et al.
Publicado: (2022)

Use of a Bacterial Artificial Chromosome to Generate Recombinant SARS-CoV-2 Expressing Robust Levels of Reporter Genes
por: Ye, Chengjin, et al.
Publicado: (2022)

Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome
por: Ye, Chengjin, et al.
Publicado: (2020)

Antibodies, B Cell Responses and Immune Responses to SARS-CoV-2 Infections
por: Martinez-Sobrido, Luis, et al.
Publicado: (2023)

Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters
por: Piepenbrink, Michael S., et al.
Publicado: (2021)

A highly efficacious live attenuated mumps virus–based SARS-CoV-2 vaccine candidate expressing a six-proline stabilized prefusion spike
por: Zhang, Yuexiu, et al.
Publicado: (2022)

A Methyltransferase-Defective Vesicular Stomatitis Virus-Based SARS-CoV-2 Vaccine Candidate Provides Complete Protection against SARS-CoV-2 Infection in Hamsters
por: Lu, Mijia, et al.
Publicado: (2021)

Vaccination to prevent T cell subversion can protect against persistent hepacivirus infection
por: Hartlage, Alex S., et al.
Publicado: (2019)

GMP Manufacturing and IND-Enabling Studies of a Recombinant Hyperimmune Globulin Targeting SARS-CoV-2
por: Mizrahi, Rena A., et al.
Publicado: (2022)

Aerosolized sulfated hyaluronan derivatives prolong the survival of K18 ACE2 mice infected with a lethal dose of SARS-CoV-2
por: Pavan, Mauro, et al.
Publicado: (2023)

Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2
por: Park, Jun-Gyu, et al.
Publicado: (2021)

A SARS-CoV-2 nucleocapsid protein TR-FRET assay amenable to high-throughput screening
por: Gorshkov, Kirill, et al.
Publicado: (2021)

SARS-CoV-2 Nucleocapsid Protein TR-FRET Assay Amenable to High Throughput Screening
por: Gorshkov, Kirill, et al.
Publicado: (2022)

Evaluating Antibody Mediated Protection against Alpha, Beta, and Delta SARS-CoV-2 Variants of Concern in K18-hACE2 Transgenic Mice
por: Wong, Ting Y., et al.
Publicado: (2022)

Amino Acid Residues Involved in Inhibition of Host Gene Expression by Influenza A/Brevig Mission/1/1918 PA-X
por: Chiem, Kevin, et al.
Publicado: (2021)

Intranasal Immunization with Liposome-Displayed Receptor-Binding Domain Induces Mucosal Immunity and Protection against SARS-CoV-2
por: Huang, Wei-Chiao, et al.
Publicado: (2022)

Contribution to pathogenesis of accessory proteins of deadly human coronaviruses
por: Hurtado-Tamayo, Jesus, et al.
Publicado: (2023)

Increasing the Safety Profile of the Master Donor Live Attenuated Influenza Vaccine
por: Hilimire, Thomas A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ahv7upbh2708rlj1nk0homm5i7